GL
GILD icon

Graypoint LLC’s Gilead Sciences GILD Stock Holding History

Graypoint LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.47M Buy
13,271
+1,115
+9% +$119K 0.08% 165
2025
Q1 		$1.36M Buy
12,156
+965
+9% +$99.6K 0.08% 160
2024
Q4 		$1.03M Buy
11,191
+1,249
+13% +$112K 0.06% 196
2024
Q3 		$834K Buy
9,942
+1,621
+19% +$124K 0.05% 216
2024
Q2 		$571K Sell
8,321
-2,282
-22% -$152K 0.04% 255
2024
Q1 		$777K Sell
10,603
-215
-2% -$16.5K 0.06% 210
2023
Q4 		$876K Buy
10,818
+745
+7% +$58K 0.07% 184
2023
Q3 		$755K Buy
10,073
+2,722
+37% +$209K 0.07% 180
2023
Q2 		$567K Buy
7,351
+670
+10% +$53.4K 0.06% 199
2023
Q1 		$554K Buy
6,681
+1,391
+26% +$115K 0.06% 189
2022
Q4 		$454K Sell
5,290
-1,077
-17% -$85.3K 0.05% 204
2022
Q3 		$393K Buy
+6,367
New +$401K 0.05% 212

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Graypoint LLC's GILD Position: Q2 2025 in Review

Graypoint LLC increased its Gilead Sciences (GILD) stake by 9.2% in Q2 2025, buying an estimated $119K and bringing the position to 13,271 shares worth $1.47M. The position accounts for 0.08% of the portfolio, ranked #165.

Graypoint LLC first reported a position in GILD in Q3 2022 and has held it in 12 quarters since. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Graypoint LLC held 13,271 shares of Gilead Sciences worth $1.47M as of Q2 2025.
  • Graypoint LLC bought 1,115 Gilead Sciences shares in Q2 2025, an estimated $119K.
  • Gilead Sciences made up 0.08% of Graypoint LLC's portfolio in Q2 2025, its #165 holding.
  • Graypoint LLC first reported a position in Gilead Sciences in Q3 2022 and has held it in 12 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.